{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:52:42Z","timestamp":1764049962824,"version":"3.45.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer poses significant health risks and necessitates effective public health management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a deep-learning survival prediction model using TabNet and compare its performance with logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on bladder cancer patients were collected from the Putuo District subset of Shanghai Cancer Registration and Reporting System. A total of 620 patients were included, divided into a training cohort (n=434) and a validation cohort (n=186). Logistic regression analyses were conducted to identify risk factors, while the TabNet framework was used to develop a deep learning-based model. Model performance was evaluated using ROC curves, decision curve analysis, and calibration curves. Shapley Additive Explanations (SHAP) was applied to interpret feature importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline characteristics showed no significant differences between the training and validation cohorts (P&amp;gt;0.05). The TabNet model demonstrated high discriminative ability in predicting both 5-year OS and CSS within the training cohort, with net benefits surpassing those of logistic regression, and showed good calibration. In the validation cohort, the TabNet model exhibited excellent performance in predicting 5-year OS and CSS. SHAP analysis revealed that age, T stage, and N stage were the most influential factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The TabNet model showed robust performance in predicting bladder cancer survival, offering valuable insights for community-based management and follow-up strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1619309","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:11:29Z","timestamp":1764047489000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning-based survival analysis of bladder cancer patients in the Putuo District, Shanghai, China"],"prefix":"10.3389","volume":"15","author":[{"given":"Wang","family":"Ruojing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Feiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Lijuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Yicen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e82430","DOI":"10.1371\/journal.pone.0082430","article-title":"Incidence trends of urinary bladder and kidney cancers in urban Shanghai, 1973-2005","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-022-00047-3","article-title":"Incidence, mortality features and lifetime risk estimation of digestive tract cancers in an urban district of shanghai, China","volume":"12","author":"Bi","year":"2022","journal-title":"J Epidemiol Glob Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e004128","DOI":"10.1136\/bmjgh-2020-004128","article-title":"Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019","volume":"6","author":"Safiri","year":"2021","journal-title":"BMJ Glob Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100326","DOI":"10.1016\/j.jcpo.2022.100326","article-title":"Socio-economic burden of disease: Survivorship costs for bladder cancer","volume":"32","author":"Michaeli","year":"2022","journal-title":"J Cancer Policy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000078","article-title":"The burden of bladder cancer care: direct and indirect costs","volume":"24","author":"Mossanen","year":"2014","journal-title":"Curr Opin Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000515650","article-title":"Substaging of pT1 urothelial bladder carcinoma predicts tumor progression and overall survival","volume":"106","author":"Grobet-Jeandin","year":"2022","journal-title":"Urol Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12484","article-title":"External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder","volume":"114","author":"Al-Daghmin","year":"2014","journal-title":"BJU Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0210976","DOI":"10.1371\/journal.pone.0210976","article-title":"Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients","volume":"14","author":"Hasnain","year":"2019","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-03000-5","article-title":"Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer","volume":"38","author":"Suarez-Ibarrola","year":"2020","journal-title":"World J Urol"},{"key":"B13","first-page":"07442","article-title":"TabNet: Attentive Interpretable Tabular Learning","volume-title":"In Proceedings of the AAAI Conference on Artificial Intelligence","author":"Arik","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12967-023-04175-7","article-title":"Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases","volume":"21","author":"Saber","year":"2023","journal-title":"J Transl Med"},{"key":"B15","volume-title":"Check and conver-sion programs for cancer registries. IARC technical report No.42.Lyon","author":"Ferlay","year":"2005"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.032","article-title":"Evaluation of data quality in the cancer registry:Principles and methods. Part I:comparability,validity and timeliness","volume":"45","author":"BRAY","year":"2009","journal-title":"Eur J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.12.001","article-title":"Bladder cancer","volume":"29","author":"Bellmunt","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.028","article-title":"Urinary tract cancer survival in Europe 1999\u20132007: results of the population-based study EUROCARE-5","volume":"51","author":"Marcos-Gragera","year":"2015","journal-title":"Eur J Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2013.02.002","article-title":"Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis","volume":"37","author":"Abdollah","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40880-015-0001-2","article-title":"Annual report on status of cancer in China, 2011","volume":"27","author":"Chen","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12885-021-08418-y","article-title":"Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival","volume":"21","author":"Ripoll","year":"2021","journal-title":"BMC Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e17725","DOI":"10.1097\/MD.0000000000017725","article-title":"Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases","volume":"98","author":"Zhang","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12957-021-02327-x","article-title":"Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study","volume":"19","author":"He","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2174\/0115748936288453240124082031","article-title":"Integrated machine learning algorithms for stratification of patients with bladder cancer","volume":"19","author":"He","year":"2024","journal-title":"Curr Bioinf"},{"key":"B26","doi-asserted-by":"publisher","first-page":"193.e7","DOI":"10.1016\/j.urolonc.2020.05.009","article-title":"Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer","volume":"39","author":"Bhambhvani","year":"2021","journal-title":"Urol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12012","article-title":"Emerging role of deep learning-based artificial intelligence in tumor pathology","volume":"40","author":"Jiang","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14377","article-title":"Artificial intelligence in oncology","volume":"111","author":"Shimizu","year":"2020","journal-title":"Cancer Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10732748231152322","DOI":"10.1177\/10732748231152322","article-title":"Impact of age at diagnosis of bladder cancer on survival: A surveillance, epidemiology, and end results-based study 2004-2015","volume":"30","author":"Lin","year":"2023","journal-title":"Cancer Control"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa273","article-title":"Sex- and age-related differences in the distribution of bladder cancer metastases","volume":"51","author":"Rosiello","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"B31","volume-title":"Campbell-Walsh urology: expert consult premium edition: enhanced online features and print, 4-volume set","author":"Wein","year":"2011"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.07.020","article-title":"Bladder cancer in the elderly","volume":"27","author":"Shariat","year":"2009","journal-title":"Urol Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-46","article-title":"Incidence, prognostic factors and survival in bladder cancer patients: a population-based study","volume":"11","author":"Wang","year":"2022","journal-title":"Transl Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00947","article-title":"Identification of biomarkers correlated with the TNM staging and overall survival of patients with bladder cancer","volume":"8","author":"Li","year":"2017","journal-title":"Front Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.0183","article-title":"Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study","volume":"30","author":"Agudo","year":"2012","journal-title":"J Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/1471-2407-14-406","article-title":"Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea","volume":"14","author":"Park","year":"2014","journal-title":"BMC Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.08.026","article-title":"Smoking and survival after radical cystectomy for bladder cancer","volume":"80","author":"Lee","year":"2012","journal-title":"Urology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2017.125","article-title":"Characteristics and clinical significance of histological variants of bladder cancer","volume":"14","author":"Moschini","year":"2017","journal-title":"Nat Rev Urol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1164401","article-title":"Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1619309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:11:30Z","timestamp":1764047490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1619309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":41,"alternative-id":["10.3389\/fonc.2025.1619309"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1619309","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"1619309"}}